# Quality of Life, Treatment Experience and Cost of Treatment With Somatostatin Analogues in Patients With Gastroenteropancreatic Neuroendocrine Tumours

> **NCT02788565** · — · COMPLETED · sponsor: **Ipsen** · enrollment: 156 (actual)

## Conditions studied

- Gastroenteropancreatic Neuroendocrine Tumours

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02788565
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2016-10
- **Final completion:** 2016-12
- **Target enrollment:** 156 (ACTUAL)
- **Last updated:** 2020-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02788565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02788565, "Quality of Life, Treatment Experience and Cost of Treatment With Somatostatin Analogues in Patients With Gastroenteropancreatic Neuroendocrine Tumours". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02788565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*